{"id":3289,"date":"2023-02-23T19:05:00","date_gmt":"2023-02-23T12:05:00","guid":{"rendered":"https:\/\/www.eurogroupconsulting.com\/?p=3289"},"modified":"2025-08-25T18:57:43","modified_gmt":"2025-08-25T11:57:43","slug":"plan-de-relance-france-2030-quelle-transformation-du-systeme-sante","status":"publish","type":"post","link":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante","title":{"rendered":"Plan de Relance France 2030 - How can the healthcare system be transformed?"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"3289\" class=\"elementor elementor-3289\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7fca7baa e-con-full e-flex e-con e-parent\" data-id=\"7fca7baa\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-51a83577 elementor-widget elementor-widget-text-editor\" data-id=\"51a83577\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\tIn June 2021, the government announces the health component of France 2030<strong>\u00a0\"Innovation Sant\u00e9 2030<\/strong>. It includes a package of legislative and regulatory measures and 7.5 billion euros to make France the most innovative and sovereign healthcare nation in Europe.\n\nOne year after its deployment,\u00a0<a href=\"https:\/\/www.eurogroupconsulting.com\/en\/the-firm\/our-partners\/matthieu-sainton\/\" target=\"_blank\" rel=\"noopener\">Matthieu Sainton<\/a>Partner in charge of the Health, Social &amp; Solidarity sector at Eurogroup Consulting, explains the \"Innovation Sant\u00e9 2030\" plan.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-1a6fe4f e-flex e-con-boxed e-con e-parent\" data-id=\"1a6fe4f\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-69c016a elementor-widget elementor-widget-text-editor\" data-id=\"69c016a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>OBJECTIVES AND DEPLOYMENT OF THE FRANCE 2030 RECOVERY PLAN<\/h3><hr size=\"2\" width=\"100%\" \/><p style=\"font-size: 24px;\"><strong><br \/>Learning from the health crisis: repairing the past<\/strong><\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p>The Covid-19 epidemic showed\u00a0<strong>strategic importance<\/strong>\u00a0of the healthcare industries sector and the decisive aspect of<strong>\u00a0French sovereignty in healthcare<\/strong>. A few figures illustrate the need for\u00a0<strong>secure access<\/strong>\u00a0drugs and medical devices.<\/p><ul><li><strong>Balance of trade :<\/strong>\u00a0in pharmaceuticals\/medical devices, France produces 51% of its products in France. And 49% outside France. By way of comparison, Germany produces 58% on its territory, and Italy 64%.<\/li><li><strong>Access to medicines and medical devices :<\/strong>\u00a017% have a very high supply vulnerability index and 23% a medium vulnerability index. That's 40% of products that are vulnerable in our consumption.<\/li><\/ul><\/div><\/div><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p><br \/>Furthermore, according to\u00a0<a href=\"https:\/\/theshiftproject.org\/\" target=\"_blank\" rel=\"noopener nofollow norefferer\">The Shift Project<\/a>These imports of medicines and medical devices account for 33% of the healthcare sector's greenhouse gas emissions. It is vital to build a solid, innovative industrial base in the healthcare sector. The challenge is to commit France to a\u00a0<strong>reindustrialization and relocation of production<\/strong>\u00a0of these products.<\/p><\/div><\/div><p style=\"font-size: 24px;\"><strong><br \/>The 2030 healthcare innovation plan: preparing for the future<\/strong><\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p>The \"Innovation Sant\u00e9 2030\" plan\u00a0<strong>7.5 billion euros<\/strong>\u00a0to make France the most innovative and sovereign healthcare nation in Europe. In concrete terms, it's a plan to stimulate public spending - or a Keynesian investment plan.<\/p><p><strong>It comprises 7 strategic areas:<\/strong><\/p><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bd0ab71 elementor-widget elementor-widget-text-editor\" data-id=\"bd0ab71\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><h4>Strengthening biomedical research<\/h4><\/div><hr size=\"2\" width=\"10%\" \/><\/div><div class=\"vc_separator wpb_content_element vc_separator_align_center vc_sep_width_10 vc_sep_border_width_2 vc_sep_pos_align_left vc_separator_no_text vc_custom_1608644985056 wpb_content_element vc_custom_1608644985056 wpb_content_element\">\u00a0<\/div><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p>With the<strong>emergence of IHU and new clusters<\/strong>the strengthening of\u00a0<strong>training<\/strong>\u00a0and the<strong>hosting researchers<\/strong>.<\/p><p>\u00a0<\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><h4>Creation of a health innovation agency<\/h4><\/div><hr size=\"2\" width=\"10%\" \/><\/div><div class=\"vc_separator wpb_content_element vc_separator_align_center vc_sep_width_10 vc_sep_border_width_2 vc_sep_pos_align_left vc_separator_no_text vc_custom_1608644985056 wpb_content_element vc_custom_1608644985056 wpb_content_element\">\u00a0<\/div><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p>To create a<strong>\u00a0pulse<\/strong>\u00a0and a\u00a0<strong>strategic innovation management<\/strong>\u00a0(the contours of which have yet to be defined, as many initiatives already exist).<\/p><p>\u00a0<\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><h4>Providing a predictable, coherent economic framework conducive to business opportunities<\/h4><\/div><hr size=\"2\" width=\"10%\" \/><\/div><div class=\"vc_separator wpb_content_element vc_separator_align_center vc_sep_width_10 vc_sep_border_width_2 vc_sep_pos_align_left vc_separator_no_text vc_custom_1608644985056 wpb_content_element vc_custom_1608644985056 wpb_content_element\">\u00a0<\/div><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p><strong>Purchasing policy<\/strong>\u00a0of healthcare establishments plays an essential role in guaranteeing security of supply and enabling the development of small\/medium-sized businesses and start-ups. To be able to anticipate and follow the regulation of the sector, companies need visibility.<\/p><p>\u00a0<\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><h4>Supporting forward-looking sectors in the healthcare industry<\/h4><\/div><hr size=\"2\" width=\"10%\" \/><\/div><div class=\"vc_separator wpb_content_element vc_separator_align_center vc_sep_width_10 vc_sep_border_width_2 vc_sep_pos_align_left vc_separator_no_text vc_custom_1608644985056 wpb_content_element vc_custom_1608644985056 wpb_content_element\">\u00a0<\/div><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p><strong>Innovative therapies, biotherapies, digital health<\/strong>... for 2.5 million euros.<\/p><p>\u00a0<\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><h4>Fair access to healthcare<\/h4><\/div><hr size=\"2\" width=\"10%\" \/><\/div><div class=\"vc_separator wpb_content_element vc_separator_align_center vc_sep_width_10 vc_sep_border_width_2 vc_sep_pos_align_left vc_separator_no_text vc_custom_1608644985056 wpb_content_element vc_custom_1608644985056 wpb_content_element\">\u00a0<\/div><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p>For patients and\u00a0<strong>provide a framework for accelerated market access for innovations<\/strong>\u00a0telehealth, innovative procedures - including non-nomenclature procedures and treatments.<\/p><p>\u00a0<\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><h4>Supporting the industrialization of healthcare products<\/h4><\/div><hr size=\"2\" width=\"10%\" \/><\/div><div class=\"vc_separator wpb_content_element vc_separator_align_center vc_sep_width_10 vc_sep_border_width_2 vc_sep_pos_align_left vc_separator_no_text vc_custom_1608644985056 wpb_content_element vc_custom_1608644985056 wpb_content_element\">\u00a0<\/div><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p>To accompany<strong>\u00a0company growth<\/strong>3.5 billion in BPI funds.<\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><h4>\u00a0<\/h4><h4>Strengthening clinical trials in France<\/h4><\/div><hr size=\"2\" width=\"10%\" \/><\/div><div class=\"vc_separator wpb_content_element vc_separator_align_center vc_sep_width_10 vc_sep_border_width_2 vc_sep_pos_align_left vc_separator_no_text vc_custom_1608644985056 wpb_content_element vc_custom_1608644985056 wpb_content_element\">\u00a0<\/div><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone wp-image-3293 size-full\" src=\"https:\/\/www.eurogroupconsulting.com\/wp-content\/uploads\/2025\/08\/21489201411.jpg\" alt=\"\" width=\"1500\" height=\"844\" srcset=\"https:\/\/www.eurogroupconsulting.com\/wp-content\/uploads\/2025\/08\/21489201411.jpg 1500w, https:\/\/www.eurogroupconsulting.com\/wp-content\/uploads\/2025\/08\/21489201411-300x169.jpg 300w, https:\/\/www.eurogroupconsulting.com\/wp-content\/uploads\/2025\/08\/21489201411-1024x576.jpg 1024w, https:\/\/www.eurogroupconsulting.com\/wp-content\/uploads\/2025\/08\/21489201411-768x432.jpg 768w\" sizes=\"(max-width: 1500px) 100vw, 1500px\" \/><\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-c5de880 e-con-full e-flex e-con e-child\" data-id=\"c5de880\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-066bc44 elementor-widget elementor-widget-text-editor\" data-id=\"066bc44\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p style=\"font-size: 24px;\"><strong>National sovereignty as a strategic and commercial opportunity<\/strong><\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p><br \/>French strategic and vulnerable products represent\u00a0<strong>100 billion euros of imports.<\/strong>\u00a0<strong>35% can be relocated to France<\/strong>\u00a0because they come from iso-competitive geographies.<\/p><p><strong>The top 4 strategic and vulnerable products include :<\/strong><\/p><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c9685e1 elementor-widget elementor-widget-text-editor\" data-id=\"c9685e1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><h4>Medical devices<\/h4><\/div><hr size=\"2\" width=\"10%\" \/><\/div><div class=\"vc_separator wpb_content_element vc_separator_align_center vc_sep_width_10 vc_sep_border_width_2 vc_sep_pos_align_left vc_separator_no_text vc_custom_1608644985056 wpb_content_element vc_custom_1608644985056 wpb_content_element\">\u00a0<\/div><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p>Prostheses, joints and artificial organs, optics... represent\u00a0<strong>5 billion euros of imports<\/strong>\u00a0(in terms of sales), with a\u00a0<strong>relocation potential of 35%<\/strong>\u00a0(or 1.8 billion euros in added value).<\/p><p>\u00a0<\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><h4>Medical equipment<\/h4><\/div><hr size=\"2\" width=\"10%\" \/><\/div><div class=\"vc_separator wpb_content_element vc_separator_align_center vc_sep_width_10 vc_sep_border_width_2 vc_sep_pos_align_left vc_separator_no_text vc_custom_1608644985056 wpb_content_element vc_custom_1608644985056 wpb_content_element\">\u00a0<\/div><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p>Medical equipment (therapeutic, such as respirators, and diagnostic, such as radiology) accounts for\u00a0<strong>2 billion euros of imports<\/strong>\u00a0(in terms of sales), with a\u00a0<strong>30% relocation potential<\/strong>\u00a0(equivalent to 630 million euros of added value).<\/p><p>\u00a0<\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><h4>Hormones<\/h4><\/div><hr size=\"2\" width=\"10%\" \/><\/div><div class=\"vc_separator wpb_content_element vc_separator_align_center vc_sep_width_10 vc_sep_border_width_2 vc_sep_pos_align_left vc_separator_no_text vc_custom_1608644985056 wpb_content_element vc_custom_1608644985056 wpb_content_element\">\u00a0<\/div><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p>Hormones represent a total of\u00a0<strong>2.6 billion euros of imports<\/strong>\u00a0(in terms of sales), with a\u00a0<strong>relocation potential of 50%<\/strong>\u00a0(or 1.3 billion euros in added value).<\/p><p>\u00a0<\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><h4>Antibiotics and antibacterials<\/h4><\/div><hr size=\"2\" width=\"10%\" \/><\/div><div class=\"vc_separator wpb_content_element vc_separator_align_center vc_sep_width_10 vc_sep_border_width_2 vc_sep_pos_align_left vc_separator_no_text vc_custom_1608644985056 wpb_content_element vc_custom_1608644985056 wpb_content_element\">\u00a0<\/div><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p>They represent\u00a0<strong>1.2 billion euros of imports<\/strong>\u00a0(in terms of sales), with a\u00a0<strong>30% relocation potential<\/strong>\u00a0(i.e. 350 million euros of added value).<\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-a809fcc e-con-full e-flex e-con e-child\" data-id=\"a809fcc\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-4a3e270 e-con-full e-flex e-con e-child\" data-id=\"4a3e270\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f873515 elementor-widget elementor-widget-text-editor\" data-id=\"f873515\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<center><span style=\"font-size: 22px;\">10.8 billion euros<\/span><\/center><center>of imports present a potential for relocation<\/center><p>\u00a0<\/p><center>and therefore added value for the French economy (~4 billion euros for this industry).<\/center>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-54c4c81 e-con-full e-flex e-con e-child\" data-id=\"54c4c81\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-642beb7 elementor-widget elementor-widget-text-editor\" data-id=\"642beb7\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<center><span style=\"font-size: 22px;\">650Million euros<\/span><\/center><center>the development and production of innovative medical devices, digital solutions and disruptive healthcare solutions<\/center><br><center>In addition, the production of 20 biomedicines to treat cancers and chronic diseases, including age-related illnesses, is worth 2.3 billion euros.<\/center>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-92e6162 e-con-full e-flex e-con e-child\" data-id=\"92e6162\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-1ca5fb9 elementor-widget elementor-widget-text-editor\" data-id=\"1ca5fb9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<center><h4 class=\"vc_custom_heading vc_do_custom_heading vc_custom_1677077767146\">It's a real dynamic that's taking shape, and a business opportunity for French and international players, both public and private.<\/h4><\/center>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-f0fca2c e-flex e-con-boxed e-con e-parent\" data-id=\"f0fca2c\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-37cbd3e elementor-widget elementor-widget-text-editor\" data-id=\"37cbd3e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h3>TOWARDS A TRANSFORMATION OF THE HEALTHCARE SYSTEM<\/h3><hr size=\"2\" width=\"100%\" \/><p style=\"font-size: 24px;\"><strong><br \/>The essential role of collective initiatives<\/strong><\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p>The numerous calls for projects are aimed at <strong>strengthen existing bridges between collective initiatives in basic research, applied research and marketing.<\/strong>\u00a0Today, an IHU that does not take the industrial environment into account is less likely to succeed.<\/p><p>A BioCluster focused solely on industrial players does not meet these expectations. Calls for projects and major policies now require all players to work together to develop collective projects.<\/p><p>At the same time, numerous local initiatives are taking shape. For example, Art 51s, initiatives linked to all the structures that help accelerate projects: PSC, Digital Pharma Lab, HHC... These collective initiatives are essential. They help to build a common culture around healthcare, but also to foster key innovations.<\/p><p>These collective initiatives are essential.<strong>\u00a0They help to build a common culture around healthcare, but also to foster key innovations.<\/strong><\/p><p>\u00a0<\/p><\/div><\/div><p style=\"font-size: 24px;\"><strong>Increasing the skills of local authorities<\/strong><\/p><div class=\"wpb_text_column wpb_content_element\"><div class=\"wpb_wrapper\"><p><strong>The sector's lack of appeal<\/strong>\u00a0is weighing on healthcare providers, particularly hospitals and private practitioners. The situation seems to be at a standstill: despite rising salaries and multiple revisions to hospital governance, many professionals (in operating theatres, EHPADs, etc.) are still missing in action.<\/p><p>Banking on<strong>\u00a0the development of differentiated territorial logics<\/strong>\u00a0could well be the key to the problem. Local authorities, having taken a liking to their commitment to healthcare players during the Covid-19 crisis, are increasingly taking up these issues. The regions, d\u00e9partements and even communes are taking numerous initiatives (financing housing, helping people to set up in business, prevention initiatives, etc.). They are growing in competence, which augurs well for a strengthening of their role in the future.<\/p><p>Nevertheless, it should be remembered that it took over 10 years to actually implement activity-based pricing (T2A). We can therefore assume that changing the system will take time...<\/p><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>In June 2021, the government announced the health component of France 2030 \"Innovation Sant\u00e9 2030\". It includes a package of legislative and regulatory measures as well as 7.5 billion euros to make France the most innovative and sovereign healthcare nation in Europe.<\/p>","protected":false},"author":1,"featured_media":3292,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[32],"tags":[],"class_list":["post-3289","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-article"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Plan de Relance France 2030 \u2013 Quelle transformation du syst\u00e8me de sant\u00e9 ? - Eurogroup Consulting<\/title>\n<meta name=\"description\" content=\"Plan de relance France 2030, quelles sont les strat\u00e9gies \u00e0 mettre en place pour transformer le syst\u00e8me de sant\u00e9 Fran\u00e7ais ?\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-sante\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Plan de Relance France 2030 \u2013 Quelle transformation du syst\u00e8me de sant\u00e9 ? - Eurogroup Consulting\" \/>\n<meta property=\"og:description\" content=\"Plan de relance France 2030, quelles sont les strat\u00e9gies \u00e0 mettre en place pour transformer le syst\u00e8me de sant\u00e9 Fran\u00e7ais ?\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-sante\" \/>\n<meta property=\"og:site_name\" content=\"Eurogroup Consulting\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-23T12:05:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-25T11:57:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.eurogroupconsulting.com\/wp-content\/uploads\/2025\/08\/Last-1-2054x1027-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2054\" \/>\n\t<meta property=\"og:image:height\" content=\"1027\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"EGCAdmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"EGCAdmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/publications\\\/article\\\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/publications\\\/article\\\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante\"},\"author\":{\"name\":\"EGCAdmin\",\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/#\\\/schema\\\/person\\\/67bdd8879484746efdcb1f4f9c3ea0af\"},\"headline\":\"Plan de Relance France 2030 \u2013 Quelle transformation du syst\u00e8me de sant\u00e9 ?\",\"datePublished\":\"2023-02-23T12:05:00+00:00\",\"dateModified\":\"2025-08-25T11:57:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/publications\\\/article\\\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante\"},\"wordCount\":1268,\"publisher\":{\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/publications\\\/article\\\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Last-1-2054x1027-1.jpg\",\"articleSection\":[\"Article\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/publications\\\/article\\\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante\",\"url\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/publications\\\/article\\\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante\",\"name\":\"Plan de Relance France 2030 \u2013 Quelle transformation du syst\u00e8me de sant\u00e9 ? - Eurogroup Consulting\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/publications\\\/article\\\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/publications\\\/article\\\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Last-1-2054x1027-1.jpg\",\"datePublished\":\"2023-02-23T12:05:00+00:00\",\"dateModified\":\"2025-08-25T11:57:43+00:00\",\"description\":\"Plan de relance France 2030, quelles sont les strat\u00e9gies \u00e0 mettre en place pour transformer le syst\u00e8me de sant\u00e9 Fran\u00e7ais ?\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/publications\\\/article\\\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/publications\\\/article\\\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/publications\\\/article\\\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#primaryimage\",\"url\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Last-1-2054x1027-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Last-1-2054x1027-1.jpg\",\"width\":2054,\"height\":1027},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/publications\\\/article\\\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Article\",\"item\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/category\\\/article\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Plan de Relance France 2030 \u2013 Quelle transformation du syst\u00e8me de sant\u00e9 ?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/\",\"name\":\"Eurogroup Consulting\",\"description\":\"Leading Positive Transformation\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/#organization\",\"name\":\"Eurogroup Consulting\",\"url\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/logo-header-light.png\",\"contentUrl\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/logo-header-light.png\",\"width\":260,\"height\":256,\"caption\":\"Eurogroup Consulting\"},\"image\":{\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/#\\\/schema\\\/person\\\/67bdd8879484746efdcb1f4f9c3ea0af\",\"name\":\"EGCAdmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/573d1711285ac132bd63bc1d7345695d395dda4bb4479205322ae3675a2eda64?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/573d1711285ac132bd63bc1d7345695d395dda4bb4479205322ae3675a2eda64?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/573d1711285ac132bd63bc1d7345695d395dda4bb4479205322ae3675a2eda64?s=96&d=mm&r=g\",\"caption\":\"EGCAdmin\"},\"sameAs\":[\"https:\\\/\\\/www.eurogroupconsulting.com\"],\"url\":\"https:\\\/\\\/www.eurogroupconsulting.com\\\/en\\\/author\\\/egcadmin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Plan de Relance France 2030 - How can the healthcare system be transformed? - Eurogroup Consulting","description":"Plan de relance France 2030, what strategies are needed to transform the French healthcare system?","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-sante","og_locale":"en_US","og_type":"article","og_title":"Plan de Relance France 2030 \u2013 Quelle transformation du syst\u00e8me de sant\u00e9 ? - Eurogroup Consulting","og_description":"Plan de relance France 2030, quelles sont les strat\u00e9gies \u00e0 mettre en place pour transformer le syst\u00e8me de sant\u00e9 Fran\u00e7ais ?","og_url":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-sante","og_site_name":"Eurogroup Consulting","article_published_time":"2023-02-23T12:05:00+00:00","article_modified_time":"2025-08-25T11:57:43+00:00","og_image":[{"width":2054,"height":1027,"url":"https:\/\/www.eurogroupconsulting.com\/wp-content\/uploads\/2025\/08\/Last-1-2054x1027-1.jpg","type":"image\/jpeg"}],"author":"EGCAdmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"EGCAdmin","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#article","isPartOf":{"@id":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante"},"author":{"name":"EGCAdmin","@id":"https:\/\/www.eurogroupconsulting.com\/en\/#\/schema\/person\/67bdd8879484746efdcb1f4f9c3ea0af"},"headline":"Plan de Relance France 2030 \u2013 Quelle transformation du syst\u00e8me de sant\u00e9 ?","datePublished":"2023-02-23T12:05:00+00:00","dateModified":"2025-08-25T11:57:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante"},"wordCount":1268,"publisher":{"@id":"https:\/\/www.eurogroupconsulting.com\/en\/#organization"},"image":{"@id":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#primaryimage"},"thumbnailUrl":"https:\/\/www.eurogroupconsulting.com\/wp-content\/uploads\/2025\/08\/Last-1-2054x1027-1.jpg","articleSection":["Article"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante","url":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante","name":"Plan de Relance France 2030 - How can the healthcare system be transformed? - Eurogroup Consulting","isPartOf":{"@id":"https:\/\/www.eurogroupconsulting.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#primaryimage"},"image":{"@id":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#primaryimage"},"thumbnailUrl":"https:\/\/www.eurogroupconsulting.com\/wp-content\/uploads\/2025\/08\/Last-1-2054x1027-1.jpg","datePublished":"2023-02-23T12:05:00+00:00","dateModified":"2025-08-25T11:57:43+00:00","description":"Plan de relance France 2030, what strategies are needed to transform the French healthcare system?","breadcrumb":{"@id":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#primaryimage","url":"https:\/\/www.eurogroupconsulting.com\/wp-content\/uploads\/2025\/08\/Last-1-2054x1027-1.jpg","contentUrl":"https:\/\/www.eurogroupconsulting.com\/wp-content\/uploads\/2025\/08\/Last-1-2054x1027-1.jpg","width":2054,"height":1027},{"@type":"BreadcrumbList","@id":"https:\/\/www.eurogroupconsulting.com\/en\/publications\/article\/plan-de-relance-france-2030-quelle-transformation-du-systeme-de-sante#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.eurogroupconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Article","item":"https:\/\/www.eurogroupconsulting.com\/category\/article"},{"@type":"ListItem","position":3,"name":"Plan de Relance France 2030 \u2013 Quelle transformation du syst\u00e8me de sant\u00e9 ?"}]},{"@type":"WebSite","@id":"https:\/\/www.eurogroupconsulting.com\/en\/#website","url":"https:\/\/www.eurogroupconsulting.com\/en\/","name":"Eurogroup Consulting","description":"Leading Positive Transformation","publisher":{"@id":"https:\/\/www.eurogroupconsulting.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.eurogroupconsulting.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.eurogroupconsulting.com\/en\/#organization","name":"Eurogroup Consulting","url":"https:\/\/www.eurogroupconsulting.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.eurogroupconsulting.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.eurogroupconsulting.com\/wp-content\/uploads\/2025\/07\/logo-header-light.png","contentUrl":"https:\/\/www.eurogroupconsulting.com\/wp-content\/uploads\/2025\/07\/logo-header-light.png","width":260,"height":256,"caption":"Eurogroup Consulting"},"image":{"@id":"https:\/\/www.eurogroupconsulting.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.eurogroupconsulting.com\/en\/#\/schema\/person\/67bdd8879484746efdcb1f4f9c3ea0af","name":"EGCAdmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/573d1711285ac132bd63bc1d7345695d395dda4bb4479205322ae3675a2eda64?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/573d1711285ac132bd63bc1d7345695d395dda4bb4479205322ae3675a2eda64?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/573d1711285ac132bd63bc1d7345695d395dda4bb4479205322ae3675a2eda64?s=96&d=mm&r=g","caption":"EGCAdmin"},"sameAs":["https:\/\/www.eurogroupconsulting.com"],"url":"https:\/\/www.eurogroupconsulting.com\/en\/author\/egcadmin"}]}},"_links":{"self":[{"href":"https:\/\/www.eurogroupconsulting.com\/en\/wp-json\/wp\/v2\/posts\/3289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eurogroupconsulting.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.eurogroupconsulting.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.eurogroupconsulting.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eurogroupconsulting.com\/en\/wp-json\/wp\/v2\/comments?post=3289"}],"version-history":[{"count":20,"href":"https:\/\/www.eurogroupconsulting.com\/en\/wp-json\/wp\/v2\/posts\/3289\/revisions"}],"predecessor-version":[{"id":3316,"href":"https:\/\/www.eurogroupconsulting.com\/en\/wp-json\/wp\/v2\/posts\/3289\/revisions\/3316"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.eurogroupconsulting.com\/en\/wp-json\/wp\/v2\/media\/3292"}],"wp:attachment":[{"href":"https:\/\/www.eurogroupconsulting.com\/en\/wp-json\/wp\/v2\/media?parent=3289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.eurogroupconsulting.com\/en\/wp-json\/wp\/v2\/categories?post=3289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eurogroupconsulting.com\/en\/wp-json\/wp\/v2\/tags?post=3289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}